Quick Summary:
In a world increasingly driven by data and scientific advancement, the global metagenomics market is emerging as a vital field of study. Known for its ability to analyze and decode microbial genomes from environmental samples, metagenomics holds tremendous potential for a variety of applications, from diagnosing infectious diseases and making environmental remediations to characterizing gut microbes and biofuels development. Leveraging technology such as sequencing and bioinformatics yields valuable scientific insights that can pave the way for innovative solutions and sustainable practices.
Increasing prevalence of virus-inducing infections worldwide and the critical demand for timely disease diagnoses have been key contributors to market expansion. Alongside this, the functional application of metagenomics in identifying potential foodborne pathogens, coupled with its efficiency and accuracy over traditional methodologies, has significantly pushed market growth. As technological advancements continue, particularly in the realm of next-generation sequencing services, the relevance and potential of metagenomics are set to increase further, augmented by extensive R&D in life sciences and its increasing utilization in agriculture. Make an informed investment in this thriving market with our comprehensive market research report.
The global metagenomics market size reached US$ 452.9 Million in 2021. Looking forward, the publisher expects the market to reach US$ 875 Million by 2027, exhibiting a CAGR of 11.6% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and diversity, thereby bypassing the need for isolation and laboratory cultivation of individual species. Metagenomics uses sequencing and bioinformatics technologies to obtain scientific insights and is utilized as a molecular tool for analyzing the deoxyribonucleic acid (DNA) acquired from the environmental samples through water, soil and human waste. The samples are further processed through sequence reading, gene prediction, binning and functional annotation. The insights are used to diagnose infectious diseases, environmental remediation, gut microbe characterization and the development of biofuels.
Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and diversity, thereby bypassing the need for isolation and laboratory cultivation of individual species. Metagenomics uses sequencing and bioinformatics technologies to obtain scientific insights and is utilized as a molecular tool for analyzing the deoxyribonucleic acid (DNA) acquired from the environmental samples through water, soil and human waste. The samples are further processed through sequence reading, gene prediction, binning and functional annotation. The insights are used to diagnose infectious diseases, environmental remediation, gut microbe characterization and the development of biofuels.
Metagenomics Market Trends:
Increasing prevalence of virus-induced infections, such as diarrhea, influenza, hepatitis B, and HIV/AIDS, across the globe, is among the key factors driving the market growth. Moreover, the rising demand for effective solutions for the timely diagnosis of neuroinfectious diseases, such as meningitis and encephalitis, is providing a thrust to the market growth. In line with this, metagenomics also aids in identifying bacterial pathogens that can lead to foodborne disease outbreaks, which is further contributing to the growth of the market. In comparison to the traditionally used technologies, metagenomics requires a lesser number of pre-sequencing steps, enhances the authenticity of long readings and offers high read accuracy. Additionally, various technological advancements, such as the development of next-generation sequencing services, are acting as other growth-inducing factors. These solutions are integrated with data analysis software for faster data analysis and sample processing. Other factors, including extensive research and development (R&D) activities in the field of life sciences, along with the increasing utilization of metagenomics for manufacturing sustainable agricultural products, are anticipated to drive the market toward growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global metagenomics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology and application.Breakup by Product:
- Instruments and Software
- Consumables
Breakup by Technology:
- Sequencing
- Bioinformatics
Breakup by Application:
- Infectious Disease Diagnosis
- Environmental Remediation
- Gut Microbe Characterization
- Biotechnology
- Biofuel
- Agriculture
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.Key Questions Answered in This Report:
- How has the global metagenomics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global metagenomics market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global metagenomics market and who are the key players?
- What is the degree of competition in the industry?
Frequently Asked Questions about the Global Metagenomics Market
What is the estimated value of the Global Metagenomics Market?
What is the growth rate of the Global Metagenomics Market?
What is the forecasted size of the Global Metagenomics Market?
Who are the key companies in the Global Metagenomics Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 143 |
| Published | October 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 452.9 Million |
| Forecasted Market Value ( USD | $ 875 Million |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Metagenomics Market
6 Market Breakup by Product
7 Market Breakup by Technology
8 Market Breakup by Application
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Agilent Technologies Inc
- Enterome
- Eurofins Scientific
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Illumina Inc
- Novogene Co. Ltd.
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- QIAGEN N.V.
- Swift Biosciences Inc. (Danaher Corporation)
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
